Covista screens attractively valued at a forward P/E of 13.2 times and a PEG of 0.88, underpinned by four consecutive earnings beats averaging more than 11% above consensus; the chief offset is negative price momentum that has not cleared the minimum threshold, keeping the entry setup cautious despite sound fundamentals.
Thesis pillars
- Negative Momentum Near Term Headwind↓Deteriorating
- Attractive Forward Valuation Low Peg↑Improving
- Solid Piotroski Financial Health→Stable
- +1 more pillar — see the Why tab for full reasoning
Covista Inc. (CVSA) Stock Analysis
Consumer Defensive · Education & Training Services
Hold if already holding. Not a fresh buy at $128.18, but acceptable to hold if already in. Reasons: Thin upside margin: 5.9%; Negative news sentiment (-0.67).
Covista is America's largest healthcare educator, serving 100,000 students and supported by an alumni network of 400,000 across five accredited institutions: Chamberlain University ("Chamberlain"), Walden University ("Walden"), American University of the Caribbean School of... Read more
Hold if already holding. Not a fresh buy at $128.18, but acceptable to hold if already in. Reasons: Thin upside margin: 5.9%; Negative news sentiment (-0.67). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 6.1/10, moderate confidence.
Passes 5/8 gates (clean insider activity, news events none recent, earnings proximity 55d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-09-04Recent Developments — Covista Inc.
Latest news
- NEWS Covista Jumps 6.3% Amid Sector-Wide Rally - AlphaStreet — AlphaStreet positive
- NEWS New Board Shake-Up Sends Covista Stock Soaring - TipRanks — TipRanks positive
- NEWS New Board Shake-Up Sends Covista Stock Soaring - tipranks.com — tipranks.com positive
- NEWS CVSA Covista posts 8.9 percent Q1 2026 earnings per share beat, shares rise 1.29 percent today. - Top Analyst Buy Signal — Newser positive
- NEWS CVSA Covista posts 8.9 percent Q1 2026 earnings per share beat, shares rise 1.29 percent today. - Expert Verified Trades — Newser positive
Generated 2026-09-04T19:02:08Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Material Events(8-K, last 90d)
- 2026-07-28Item 5.02MEDIUM(d) The Covista Inc. ("Covista") Board of Directors (the "Board") has appointed Ms. Emily Chiu and Ms. Leslie Storms as independent members of Covista's Board effective August 17, 2026. Ms. Chiu and Ms. Storms will stand for re-election at Covista's 2026 annual meeting of stockholders.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $128.18, but acceptable to hold if already in. Reasons: Thin upside margin: 5.9%; Negative news sentiment (-0.67). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Target $135.57 (+5.8%), stop $121.43 (−5.6%), A.R:R 0.7:1. Score 6.1/10, moderate confidence.
Take-profit target: $135.57 (+5.9% upside). Target $135.57 (+5.8%), stop $121.43 (−5.6%), A.R:R 0.7:1. Stop-loss: $121.43.
Thin upside margin: 5.9%; Negative news sentiment (-0.67); Negative momentum.
Covista Inc. trades at a P/E of 17.0 (forward 12.8). TrendMatrix value score: 7.2/10. Verdict: Hold.
10 analysts cover CVSA with a consensus score of 4.3/5. Average price target: $160.
What does Covista Inc. do?Covista is America's largest healthcare educator, serving 100,000 students and supported by an alumni network of...
Covista is America's largest healthcare educator, serving 100,000 students and supported by an alumni network of 400,000 across five accredited institutions: Chamberlain University ("Chamberlain"), Walden University ("Walden"), American University of the Caribbean School of Medicine ("AUC"), Ross University School of Medicine ("RUSM"), and Ross University School of Veterinary Medicine ("RUSVM"). Covista delivers education to its students at multiple campuses and online.